Because these results were confirmed irrespective of the treatment (Eta or Ada) and disease (RA or PsA), it seems that TNF antagonists do not impair the effector function of T cells, although the source of IFNγ production (i.e. NK cells) could not be precisely defined by using a whole blood assay30. This evidence concerns the gene IFNG and rheumatoid arthritis.